Does antibody-dependent epitope masking permit progressive tumour growth in the face of cell-mediated cytotoxicity?
- PMID: 1720318
- DOI: 10.1016/0167-5699(91)90065-2
Does antibody-dependent epitope masking permit progressive tumour growth in the face of cell-mediated cytotoxicity?
Abstract
It is not clear how immunogenic tumours can grow from small inocula in syngeneic hosts that mount both T-cell and B-cell responses. In this article Lionel Manson argues that antibody coats the tumour cells, protecting them from attack by cytotoxic lymphocytes, and thus permits the tumour to continue to grow and overwhelm the host. These observations may explain the paradox that an immunogenic tumour overwhelms the tumour-bearing host in the face of an ongoing anti-tumour immune response.
Comment in
-
T cells and tumors.Immunol Today. 1992 Feb;13(2):78-9. doi: 10.1016/0167-5699(92)90141-S. Immunol Today. 1992. PMID: 1575895 No abstract available.
Similar articles
-
The role of antibody in the inhibition of the growth of Meth.A tumour in syngeneic experiments in vivo and in vitro.Clin Exp Immunol. 1978 Sep;33(3):377-85. Clin Exp Immunol. 1978. PMID: 737892 Free PMC article.
-
[Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody].Zhonghua Fu Chan Ke Za Zhi. 2008 Oct;43(10):764-9. Zhonghua Fu Chan Ke Za Zhi. 2008. PMID: 19087545 Chinese.
-
The heterogenization of tumour cells with tuberculin. II. Studies of the antigenicity of tuberculin-heterogenized murine tumour cells in syngeneic BCG positive and BCG negative mice.Immunology. 1981 Feb;42(2):337-48. Immunology. 1981. PMID: 6161889 Free PMC article.
-
Anti-tumor immune responses of the tumor-bearing host: the case for antibody-mediated immunologic enhancement.Clin Immunol Immunopathol. 1994 Jul;72(1):1-8. doi: 10.1006/clin.1994.1099. Clin Immunol Immunopathol. 1994. PMID: 8020182 Review.
-
Pancreatic tumor antigens: diagnostic markers and targets for immunotherapy.Important Adv Oncol. 1992:61-77. Important Adv Oncol. 1992. PMID: 1374733 Review. No abstract available.
Cited by
-
Tumor cells express FcgammaRI which contributes to tumor cell growth and a metastatic phenotype.Neoplasia. 2001 Mar-Apr;3(2):115-24. doi: 10.1038/sj.neo.7900140. Neoplasia. 2001. PMID: 11420747 Free PMC article.
-
Anti-tumor antibody produced by human tumor-infiltrating and peripheral blood B lymphocytes.Cancer Immunol Immunother. 1994 Apr;38(4):225-32. doi: 10.1007/BF01533513. Cancer Immunol Immunother. 1994. PMID: 8168117 Free PMC article.
-
Subdominant Outer Membrane Antigens in Anaplasma marginale: Conservation, Antigenicity, and Protective Capacity Using Recombinant Protein.PLoS One. 2015 Jun 16;10(6):e0129309. doi: 10.1371/journal.pone.0129309. eCollection 2015. PLoS One. 2015. PMID: 26079491 Free PMC article.
-
Flow cytometric analysis of Th1 and Th2 cytokines in PBMCs as a parameter of immunological dysfunction in patients of superficial transitional cell carcinoma of bladder.Cancer Immunol Immunother. 2006 Jun;55(6):734-43. doi: 10.1007/s00262-005-0045-2. Epub 2005 Nov 10. Cancer Immunol Immunother. 2006. PMID: 16283306 Free PMC article.
-
A systematic review of humoral immune responses against tumor antigens.Cancer Immunol Immunother. 2009 Oct;58(10):1535-44. doi: 10.1007/s00262-009-0733-4. Epub 2009 Jun 28. Cancer Immunol Immunother. 2009. PMID: 19562338 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources